Mycobacterium tuberculosis, a gram-positive bacterium that causes tuberculosis (TB) in human is still a serious global health concern, especially in Asia where 22 high burden countries are responsible for 80% of the world's TB cases. There are more than 150 known species of M. tuberculosis. Due to its virulence, it is the world's second most infectious cause of mortality. Furthermore, it has a high contribution to the overall disease burden. Causative agent of TB in animals is Mycobacterium bovis which is responsible for zoonotic tuberculosis in humans. The death rates resulting from these mycobacterial infections are impacted by various factors, including insufficient healthcare infrastructure, socioeconomic inequality, a dense population, and co-infection. The tendency of these mycobacteria to escape host immune responses and establish persistent infections is one of the virulence factors that contributes to the severity of tuberculosis. India has a highest 21% of TB infections in overall prevalence in Asia following China has 14%, Indonesia 6%, Nigeria 5%, Bangladesh 4%, Pakistan 3%, other 13 high burden countries for TB contribute 16%, while rest of the world contributes 20%. The early detection, directly observed treatment short-course (DOTS), and vaccination programs such as Bacillus Calmette-Guérin (BCG) have been the primary control methods in Asian countries. However, obstacles like multi-drug resistant (MDR) and dense populations have made these approaches less successful. To control and completely eradicate the disease in future top priority should be given to providing access to high-quality care, upgrading the healthcare system, and tackling socioeconomic factors that contribute to tuberculosis, such as hunger and poverty. To effectively eradicate tuberculosis in Asia and globally, cross border collaboration including cooperation between governments, international organizations, and research institutes is essential.